Description
Nadecnemab Biosimilar - Anti-GFRA3 mAb - Research Grade
Target
GFRA3
Target Alias Name
Nadecnemab/IMMUNOGLOBULIN G4 (232-PROLINE)/ ANTI-(HUMAN GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR .ALPHA.3) (HUMAN MONOCLONAL REGN5069 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL REGN5069 .KAPPA.-CHAIN/ DIMER/ REGN-5069/GFRA3/anti-GFRA3
Isotype/Mimetic
IgG4/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression